| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| ly3039478 | notch-1 receptor | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Precursor T-Cell Lymphoblastic Leukemia-Lymphoma[MeSHID:D054218] Lymphoma[MeSHID:D008223] |
3.74 | phase 1/2 | unknown |
| ly3039478 | notch-4 receptor | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] Precursor T-Cell Lymphoblastic Leukemia-Lymphoma[MeSHID:D054218] Lymphoma[MeSHID:D008223] |
7.96 | phase 1/2 | unknown |
| click here to return to the previous page | ||||||||